James Flynn

James Flynn is a prominent figure in the healthcare investment sector, currently serving as the Founder of Cure and the Managing Partner at Deerfield Management. His career spans several decades, during which he has made significant contributions to healthcare innovation and investment.

Professional Background

• Cure: Founded in 2019, Cure is a healthcare innovation campus located in New York City. The initiative aims to foster economic growth by bringing together diverse individuals, innovative ideas, and advanced technology to support underfunded and underrepresented life sciences startups.45

• Deerfield Management: Flynn joined Deerfield in 2000 and became Managing Partner in 2006. Under his leadership, the firm has expanded its investment capabilities and established various initiatives, including the Deerfield Institute and the Deerfield Foundation, which focuses on health and welfare for disadvantaged children.12 Flynn has played a crucial role in integrating healthcare investment with research and philanthropy.

Education

Flynn holds a Bachelor of Science in Cellular and Molecular Biology and Economics from the University of Michigan and a Master of Science in Biotechnology from Johns Hopkins University.23

Contributions to Healthcare

Beyond his roles at Cure and Deerfield, Flynn has been involved in various boards and committees aimed at improving healthcare systems. He served as Chairman of the Quality Committee of the Board of Trustees for Continuum Health Partners and is currently the Chairman of the Board of Trustees for the New York Academy of Medicine.12

James Flynn's extensive experience in healthcare investment and his commitment to innovation make him a key player in advancing the industry.